Skip to main content
. Author manuscript; available in PMC: 2015 Nov 5.
Published in final edited form as: Pediatr Blood Cancer. 2015 Apr 30;62(8):1468–1472. doi: 10.1002/pbc.25555

Table II.

Patient details

Patient Prior HCT Diagnosis Relapse Peak Chimerism (%) Pre NK Blasts (%) Post NK Blasts (%) Response HCT after NK Status
1 No ALL 1 0 40 18 PR yes Dead
2 No ALL 1 1 2 Neg CR yes Alive
3 No AML 1 12 80 91 NR yes Dead
4 No ALL 1 17 30 Neg CR yes Alive
5 No ALL 1 82 97 Neg CR yes Dead
6 No ALL 1 100 15 Neg* CRi no Dead
7 No AML 1 100 80 14 PR no Alive
8 No ALL 1 100 37 6 PR yes Dead
9 No ALL 1 100 92 100 NR yes Dead
10 No ALL 1 100 20 96 NR yes Dead
11 No AML 1 100 40 31 NR yes Dead
12 No AML 1 100 56 2 CR yes Dead
13 No AML 1 100 12 0.3 CR yes Alive
14 No AML 1 QNS 15 Neg* CRi yes Alive
15 Yes ALL 2 0 100 100 NR yes Dead
16 Yes ALL 2 24 30 Neg CR yes Dead
17 Yes AML 2 49 10 Neg* CRi yes Dead
18 Yes ALL 2 98 90 90 NR no Dead
19 Yes ALL 2 100 14 Neg CR no Dead
20 Yes ALL 2 100 100 100 NR no Dead
21 Yes ALL 2 100 95 95 NR yes Dead
22 Yes ALL 2 100 97 Neg* CRi yes Alive
23 Yes ALL 2 100 14 3 PR yes Alive
24 Yes AML 2 100 90 36 PR yes Alive
25 Yes AML 1 100 93 Neg* CRi yes Alive
26 Yes AML 1 100 13 4 PR yes Dead
27 Yes AML 1 QNS 11 Neg* CRi no Dead
28 Yes AML 2 QNS 52 NE NE no Dead
29 Yes ALL 2 QNS 90 Neg* CRi yes Dead

Neg, negative; Neg*, no detectable blasts, but hypocellular marrow; PR, partial response; CR, complete remission; CRi, complete remission with incomplete count recovery; QNS, quantity not sufficient; NE, not evaluable.